RNAi for Therapeutic Market to Witness Robust Expansion by 2023

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

LPI (LP Information)' newest research report, the "RNAi for Therapeutic Industry Forecast" looks at past sales and reviews total world RNAi for Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected RNAi for Therapeutic sales for 2023 through 2029. With RNAi for Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNAi for Therapeutic industry.

This Insight Report provides a comprehensive analysis of the global RNAi for Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNAi for Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global RNAi for Therapeutic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNAi for Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNAi for Therapeutic.

Get More Information on this Report：
https://www.lpinformationdata.com/reports/454439/rnai-for-therapeutic-outlook-2029

The global RNAi for Therapeutic market size is projected to grow from US$ 172.2 million in 2022 to US$ 2288.1 million in 2029; it is expected to grow at a CAGR of 44.7% from 2023 to 2029.

Global RNAi for Therapeutic key players include Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, etc. Global top five manufacturers hold a share over 85%.

US is the largest market, with a share over 75%, followed by EU, which has a share about 3%.
In terms of product, siRNA is the largest segment, with a share over 55%. And in terms of application, the largest application is Cancer, followed by HBV, Cardiovascular, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of RNAi for Therapeutic market by product type, application, key players and key regions and countries.

Top Manufactures in Global New Medical Materials and Biomaterials Includes:
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

Market Segment by Type, covers:
siRNA
miRNA
shRNA

Market Segment by Applications, can be divided into:
Cancer
Cardiovascular
HBV
Others

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

For more report information, please contact us：https://www.lpinformationdata.com/contact-us

E-mail: info@lpinformationdata.com
Tel: +852-58080956(HK)/+86-13660489451(CN)
Add: 17890 Castleton St. Suite 369 City of Industry, CA 91748 US
Website: https://www.lpinformationdata.com

LP INFORMATION (LPI) is a professional market report publisher based in America, providing high quality market research reports with competitive prices to help decision makers make informed decisions and take strategic actions to achieve excellent outcomes.We have an extensive library of reports on hundreds of technologies.Search for a specific term, or click on an industry to browse our reports by subject. Narrow down your results using our filters or sort by what's important to you, such as publication date, price, or name.

This release was published on openPR.